hitcounter
This site is an rss/xml news reader containing our favorite feeds. All articles are the copyrighted material of the blogs that wrote them.

Biogen to Sell Rights to Psoriasis Drug 

Biogen to Sell Rights to Psoriasis Drug  AP via Yahoo! Finance - Apr 03 1:43 PM Biotech company Biogen Idec Inc. said Monday it agreed to sell the worldwide rights of Amevive, a psoriasis treatment, to the U.S. arm of Japanese drug maker Astellas Pharma Inc., for $60 million.Save to My Web

Read The Full Article:
http://www.drilltools.org/297


Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!
Website designed by Bartosz Brzezinski
Powered by blogdig.net